Dr. Jeffrey R. Jay, M.D

Dr. Jeffrey R. Jay, M.D. as of Dec. 31, 2012

Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.

Dr. Jeffrey R. Jay, M.D. holds 25 positions in its portfolio as reported in the December 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Furiex Pharmaceuticals 11.3 $12M 632k 19.26
ACADIA Pharmaceuticals (ACAD) 10.2 $11M 2.4M 4.65
OncoGenex Pharmaceuticals 10.1 $11M 823k 13.12
Hyperion Therapeutics 8.1 $8.7M 772k 11.28
Vanda Pharmaceuticals (VNDA) 7.9 $8.5M 2.3M 3.70
Questcor Pharmaceuticals 7.5 $8.0M 300k 26.72
Celsion Corporation 6.4 $6.9M 844k 8.19
Acelrx Pharmaceuticals 6.0 $6.5M 1.5M 4.26
Amarin Corporation (AMRN) 4.8 $5.1M 633k 8.09
EXACT Sciences Corporation (EXAS) 4.1 $4.4M 415k 10.59
Pain Therapeutics 3.5 $3.7M 1.4M 2.71
D Horizon Pharma 3.2 $3.4M 1.5M 2.33
Biodel 3.0 $3.2M 1.4M 2.35
Vascular Solutions 2.9 $3.2M 200k 15.80
RTI Biologics 2.0 $2.1M 500k 4.27
Affymax (AFFY) 1.6 $1.7M 89k 18.99
Accuray Incorporated (ARAY) 1.5 $1.6M 250k 6.43
Palatin Technologies 1.5 $1.6M 2.6M 0.60
Zogenix 1.4 $1.5M 1.1M 1.33
Targacept 1.0 $1.1M 244k 4.38
Sarepta Therapeutics (SRPT) 0.8 $828k 32k 25.81
NPS Pharmaceuticals 0.6 $687k 76k 9.10
Oncothyreon 0.6 $683k 356k 1.92
Mei Pharma 0.1 $155k 1.1M 0.14
AMAG Pharmaceuticals 0.0 $2.0k 150.00 13.33